Insights

Innovative Biotech Focus PetMedix specializes in the development of species-specific therapeutic antibodies for companion animals, leveraging cutting-edge science and proprietary platforms. This positions them as a key player in advancing veterinary biopharmaceuticals, offering opportunities for collaborations, licensing, and technology licensing with companies seeking innovative animal health solutions.

Strong Investment Backing With recent Series B funding of $37 million from prominent investors such as Tencent and Cambridge Innovation Capital, PetMedix has significant financial resources to accelerate pipeline development and clinical trials. This presents sales prospects for suppliers of laboratory equipment, clinical trial services, and biotech partners involved in early to mid-stage development.

Strategic Industry Partnerships PetMedix has established multi-year collaborations with major pharmaceutical players like Boehringer Ingelheim, highlighting its credibility and potential for joint ventures or licensing deals. Companies offering veterinary therapeutics, diagnostic tools, or R&D services can explore partnership or distribution opportunities within this network.

Market Expansion Potential As a development-stage company targeting underserved clinical areas in veterinary medicine, PetMedix is positioned for future product launches. Sales opportunities exist in supplying raw materials, manufacturing services, and regulatory consulting to support expanded clinical trials and eventual commercial product rollout.

Recognition and Growth Recognized as the best startup at the global Animal Pharm Awards, PetMedix demonstrates strong industry credibility and growth potential, making it an attractive partner or customer for advanced veterinary biotech solutions, medical advertising, and professional services to facilitate their scaling efforts.

Similar companies to PetMedix

PetMedix Tech Stack

PetMedix uses 8 technology products and services including MySQL, Twemoji, Font Awesome, and more. Explore PetMedix's tech stack below.

  • MySQL
    Database
  • Twemoji
    Font Scripts
  • Font Awesome
    Font Scripts
  • Google Cloud
    Infrastructure As A Service
  • jQuery
    Javascript Libraries
  • Elementor
    Page Builders
  • Yoast SEO
    Search Engines
  • LiteSpeed
    Web Servers

Media & News

PetMedix's Email Address Formats

PetMedix uses at least 1 format(s):
PetMedix Email FormatsExamplePercentage
First.Last@petmedix.co.ukJohn.Doe@petmedix.co.uk
48%
First.L@petmedix.co.ukJohn.D@petmedix.co.uk
2%
First.Last@petmedix.co.ukJohn.Doe@petmedix.co.uk
48%
First.L@petmedix.co.ukJohn.D@petmedix.co.uk
2%

Frequently Asked Questions

What is PetMedix's official website and social media links?

Minus sign iconPlus sign icon
PetMedix's official website is petmedix.co.uk and has social profiles on LinkedIn.

What is PetMedix's SIC code NAICS code?

Minus sign iconPlus sign icon
PetMedix's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does PetMedix have currently?

Minus sign iconPlus sign icon
As of December 2025, PetMedix has approximately 41 employees across 2 continents, including EuropeNorth America. Key team members include Chief Product Development Officer: D. L.Senior Scientist, Ngs Pipeline: C. C.Principal Research Associate: A. B.. Explore PetMedix's employee directory with LeadIQ.

What industry does PetMedix belong to?

Minus sign iconPlus sign icon
PetMedix operates in the Biotechnology Research industry.

What technology does PetMedix use?

Minus sign iconPlus sign icon
PetMedix's tech stack includes MySQLTwemojiFont AwesomeGoogle CloudjQueryElementorYoast SEOLiteSpeed.

What is PetMedix's email format?

Minus sign iconPlus sign icon
PetMedix's email format typically follows the pattern of First.Last@petmedix.co.uk. Find more PetMedix email formats with LeadIQ.

How much funding has PetMedix raised to date?

Minus sign iconPlus sign icon
As of December 2025, PetMedix has raised $37M in funding. The last funding round occurred on Sep 08, 2021 for $37M.

When was PetMedix founded?

Minus sign iconPlus sign icon
PetMedix was founded in 2017.

PetMedix

Biotechnology ResearchEngland, United Kingdom11-50 Employees

PetMedix is a development stage veterinary biopharmaceutical company based in Cambridge, UK. We are using the highest quality science to make the therapies our pets need and deserve, keeping them healthier, happier, and for longer. Building on more than thirty years of world-leading innovation and human drug development, we are applying the cutting edge of science to bring breakthroughs for the animals we love and care for. 

PetMedix is taking the experience of its founding team, and decades of human clinical research, to build platforms that generate fully species-specific, naturally-generated therapeutic antibodies. These platforms have been designed to generate a repertoire of antibodies as diverse as the companion animal immune systems on which they are based. These platforms can then be used to develop a broad pipeline of our own veterinary medicines to target under-served clinical areas that represent excellent market opportunities. 

We are actively recruiting so please get in touch if you wish to join our hard-working and talented team.

Section iconCompany Overview

SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2017
Employees
11-50

Section iconFunding & Financials

  • $37M

    PetMedix has raised a total of $37M of funding over 2 rounds. Their latest funding round was raised on Sep 08, 2021 in the amount of $37M.

  • $1M$10M

    PetMedix's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $37M

    PetMedix has raised a total of $37M of funding over 2 rounds. Their latest funding round was raised on Sep 08, 2021 in the amount of $37M.

  • $1M$10M

    PetMedix's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.